Renske J Grupstra
Overview
Explore the profile of Renske J Grupstra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grupstra R, Goedecke T, Gardarsdottir H
Clin Pharmacol Ther
. 2024 Jul;
116(5):1252-1258.
PMID: 38994581
Marketing-authorization holders evaluate the effectiveness of risk minimization measures (RMM) for medicines through the conduct of post-authorization safety studies (PASS). Earlier studies show that concluding on RMM effectiveness is challenging....
2.
Grupstra R, Siiskonen S, Gardarsdottir H
Ned Tijdschr Geneeskd
. 2024 Jun;
168.
PMID: 38888389
Objective: Risk minimisation measures (RMM) are put in place to ensure safe and effective use of medicines. This study assessed whether RMM for five medicines are implemented in Dutch clinical...
3.
Grupstra R, Goedecke T, Scheffers J, Strassmann V, Gardarsdottir H
Clin Pharmacol Ther
. 2023 Aug;
114(6):1285-1292.
PMID: 37634124
The European Medicines Agency (EMA) supervises medicines' safe and effective use throughout the product's life cycle by, for example, monitoring the implementation of risk minimization measures (RMMs). Limited information is...
4.
de Jong A, Santa-Ana-Tellez Y, Zuidgeest M, Grupstra R, Jami F, de Boer A, et al.
Br J Clin Pharmacol
. 2023 Jul;
89(12):3512-3522.
PMID: 37438875
Aims: Insights into the current practice of direct-to-participant (DtP) supply of investigational medicinal product (IMP) in the context of clinical trials conducted in Europe are needed, as regulations are unharmonized....
5.
de Jong A, Grupstra R, Santa-Ana-Tellez Y, Zuidgeest M, de Boer A, Gardarsdottir H
BMJ Open
. 2022 Aug;
12(8):e063236.
PMID: 36038171
Objectives: Decentralised clinical trial activities-such as participant recruitment via social media, data collection through wearables and direct-to-participant investigational medicinal product (IMP) supply-have the potential to change the way clinical trials...